Key Takeaways
- Planet Labs (PL) declined 2.6% during Monday’s session, touching an intraday low of $34.21 before settling near $34.96.
- The company’s CFO and President, Ashley F. Johnson, offloaded 200,000 shares on April 2, netting approximately $7 million.
- Fiscal 2026 Q4 revenue reached $86.82M — a 41.1% year-over-year increase that exceeded projections — though EPS came in sharply below expectations at ($0.48) versus the anticipated ($0.05).
- Multiple Wall Street firms increased their price objectives, with Needham and Wedbush elevating targets to $40 and Citi moving to $35.
- The satellite imaging company revealed plans to redeem all outstanding public warrants on April 27, 2026, at a price of $0.01 each.
Planet Labs (PL) experienced a 2.6% decline on Monday as market participants reacted to significant insider selling activity from a senior executive, combined with a quarterly earnings report that delivered mixed signals.
Ashley F. Johnson, serving as both CFO and President, divested 200,000 Class A shares on April 2 in a transaction valued at approximately $7 million. The disposition occurred through two separate executions — the first involving 51,460 shares at prices ranging from $34.57 to $34.94, followed by 148,540 shares executed between $34.585 and $35.87.
Additionally, on April 6, Johnson moved 525,708 shares into The Johnson Joint Revocable Trust, an entity over which she and her spouse exercise control as joint trustees.
The recent insider activity represents a continuation of elevated selling trends. Throughout the previous quarter, company insiders disposed of 218,566 shares collectively, generating proceeds just shy of $5.9 million. Director Vijaya Gadde similarly liquidated 20,000 shares during January.
Such concentrated selling activity often triggers investor caution — even when underlying business performance shows signs of strengthening.
Top-Line Growth Contrasts with Bottom-Line Disappointment
Planet Labs delivered fiscal 2026 Q4 revenue totaling $86.82 million, significantly outpacing the Wall Street consensus of $78.17 million. This represents a robust 41.1% increase compared to the prior-year period.
However, profitability metrics told a different story. The company reported a loss per share of ($0.48), substantially worse than the ($0.05) loss analysts had forecasted. The earth-imaging specialist continues to operate in the red, exhibiting a negative net margin of 80.22% and a return on equity deficit of 69.61%.
For the upcoming Q1 fiscal 2027 period, management issued revenue guidance approximately 5% above consensus projections — a forward-looking data point that helped maintain generally positive sentiment among Wall Street analysts despite the earnings shortfall.
Goldman Sachs adjusted its price target upward to $18 while maintaining a Neutral stance. Needham elevated its objective to $40, highlighting revenue and earnings beats of 11% and $0.02 respectively, and reaffirmed its Buy recommendation. Wedbush similarly increased its target from $30 to $40 accompanied by an Outperform rating. Citi raised its forecast from $30 to $35 while maintaining a Buy position.
The equity’s 50-day moving average currently stands at $26.21, with the 200-day moving average at $19.64 — both considerably beneath Monday’s closing price.
Satellite Operations and Technology Deployment
From an operational perspective, Planet Labs recently delivered three Pelican satellites to Vandenberg Space Force Base in California in preparation for an upcoming SpaceX rideshare launch. These satellites are equipped with NVIDIA’s Jetson AI platform to enable sophisticated onboard data processing capabilities.
Warrant Recall Action
The company disclosed its intention to redeem all outstanding public warrants for Class A common stock on April 27, 2026, at a redemption price of $0.01 per warrant.
Monday’s trading volume registered approximately 12.5 million shares — roughly 11% below the standard daily average of 14.1 million shares.
Planet Labs currently maintains a market capitalization of $12.10 billion, carries a debt-to-equity ratio of 2.37, and exhibits a beta coefficient of 1.83.
